Dr. Yongli Zhang's lab at Yale University focuses on understanding how proteins involved in neuron communication and lipid transfer work at a molecular level. Specifically, the research explores how SNARE proteins help trigger the fusion of synaptic vesicles, which is essential for transmitting signals between nerve cells, and how lipid transfer proteins facilitate the movement of lipids between membranes. The ultimate goal is to uncover the mechanisms behind these processes, which could help in addressing various neurological diseases.

Dr. Shyam S Krishnakumar's lab focuses on understanding the complex mechanisms of synaptic transmission, particularly the roles of proteins like Complexin and Synaptotagmin in neurotransmitter release. They use a variety of experimental approaches, including studies in model organisms such as worms and mice, to explore how these proteins interact and regulate synapse function. Their research may provide insights into neurological disorders by enhancing our understanding of synaptic exocytosis.

Dr. Kevin Navin Sheth's lab focuses on improving the accessibility and effectiveness of brain imaging and treatment for stroke patients. They are developing a portable low-field MRI to allow for real-time imaging in acute care settings, which can enhance clinical decision making. Additionally, the lab is investigating the use of anticoagulant therapy in patients who have experienced an intracerebral hemorrhage, aiming to improve patient outcomes and reduce the risk of subsequent strokes.

Dr. Vishwa Deep Dixit's lab focuses on understanding how aging and inflammation are linked to chronic diseases. By investigating the role of Fibroblast Growth Factor 21 (FGF21) and its receptor Klotho, the lab aims to uncover new strategies to enhance healthspan and lifespan by reducing age-related inflammation and metabolic dysfunction. The research includes exploring how FGF21 can be used therapeutically to combat the effects of aging.

Dr. Thomas James Melia's lab at Yale University focuses on understanding how cells deal with stress by creating autophagosomes, which are essential organelles that encapsulate and eliminate toxic components within the cell. His lab investigates the mechanisms by which cells harvest lipids necessary for autophagosome formation, especially under conditions of stress like disease or starvation. By elucidating these processes, the lab aims to provide insights into cell biology that could impact our understanding of various diseases such as infections, neurodegeneration, and cancer.

Dr. Thierry Emonet's lab at Yale University studies how bacteria navigate through their environments using a process called chemotaxis. They are particularly interested in how different species of bacteria, like E. coli and Vibrio cholerae, respond to chemical signals and how these responses affect their ability to move collectively. By understanding these behaviors, the lab aims to provide insights into bacterial infections and the dynamics of microbial populations.

Dr. Michael J. Caplan's research focuses on understanding the mechanisms behind Autosomal Dominant Polycystic Kidney Disease (ADPKD), a genetic disorder that leads to kidney dysfunction. His lab investigates the role of a specific protein fragment from polycystin-1 in preventing cyst formation and maintaining kidney health. By exploring how this fragment interacts with cellular structures and metabolism, the lab aims to identify new therapeutic targets for treating ADPKD.

The lab directed by Dr. Hongyu Zhao at Yale University focuses on understanding the genetic factors that influence brain responses to substance use disorders (SUD) and HIV. Through advanced statistical methods and single-cell analysis, their research aims to uncover how genetic variations affect molecular phenotypes in different brain regions, which could lead to new insights and applications in clinical settings. The lab also addresses health disparities in genetic risk prediction, emphasizing the need for models applicable to underrepresented populations.

Dr. Carlos Fernandez Hernando's lab focuses on understanding how lipid metabolism affects immune responses in cardiovascular diseases, particularly atherosclerosis. They study novel enzymes and lipid molecules that help regulate inflammation and cholesterol levels in macrophages, which are immune cells involved in artery health. By investigating these pathways, the lab aims to uncover potential treatments that can improve cardiovascular health by targeting the underlying causes of inflammation and lipid imbalances.

Dr. Nadya Dimitrova's lab at Yale University studies the role of long noncoding RNAs (lncRNAs), particularly Malat1, in lung adenocarcinoma (LUAD). They focus on how Malat1 contributes to cancer progression and the tumor microenvironment, using advanced mouse models and molecular biology techniques. The lab aims to uncover potential therapeutic targets by understanding how the deregulation of lncRNAs affects cancer development.

Marc Hammarlund's lab at Yale University focuses on understanding how different types of neurons in the worm C. elegans use gene expression to develop and function. They study how these neurons differ from each other at various stages of growth, including how they express genes in male and female forms. By mapping out gene expression and splicing patterns, the lab aims to uncover the complex genetic mechanisms behind neuronal diversity, which could provide insights into human neurological conditions.

Dr. Yuval Kluger’s lab at Yale University focuses on understanding how opioid use disorder (OUD) and HIV affect the brain’s cellular functions. The team utilizes advanced techniques to analyze brain tissue samples to uncover molecular changes and interactions between these two conditions, which are currently not well understood. Their goal is to identify potential targets for new treatments that can address the combined impact of OUD and HIV on the nervous system.

Dr. Steve W.C. Chang's lab at Yale University explores the intricate dynamics of social interactions, especially how primates cooperate and compete. Using advanced neural recording techniques and behavioral tracking, the team investigates how different parts of the brain, particularly the prefrontal cortex, help shape our social strategies. The research aims to uncover the underlying neural mechanisms that govern how social relationships and previous experiences influence decision-making in social contexts.

Dr. Rui Chang's lab at Yale University focuses on understanding how the brain senses signals from the body's internal organs through the vagus nerve. Using advanced molecular and genetic techniques, the lab investigates the architecture and functioning of this vital communication pathway. Their research aims to reveal how different visceral inputs are encoded and processed, paving the way for new insights into health and disease related to interoception, or the sense of the internal state of the body.

Dr. Jay D. Humphrey's lab at Yale University focuses on understanding diseases of the thoracic aorta, which can lead to serious health issues like aneurysms and dissections. The lab investigates how cells interact with their surrounding structures to maintain healthy tissue, particularly in the context of genetic conditions such as Marfan syndrome. By using advanced computational models and mouse models, the lab aims to uncover the underlying mechanisms of thoracic aortopathy and identify potential new treatment strategies.

Dr. Jordan S. Pober's lab at Yale University focuses on innovative approaches to improve organ transplantation and tissue engineering. By utilizing advanced techniques such as 3D printing and nanoparticle drug delivery, the lab aims to create human skin substitutes that enhance graft survival and reduce immune rejection. The research is highly relevant for developing better treatment options for patients requiring organ transplants.

Dr. Emily Gilmore's lab at Yale University focuses on understanding how certain brain patterns, referred to as electrographic seizures (ESz) and high-frequency periodic discharges (HF-PD), affect recovery in patients with severe traumatic brain injury (sTBI). The lab aims to establish whether these patterns indicate a worsening brain condition and how they could be treated to improve patient outcomes. Their research is crucial as it may lead to better treatment strategies for sTBI, enhancing the likelihood of recovery for affected individuals.

Dr. Peter Glazer's lab focuses on finding ways to treat cancer by targeting specific weaknesses in tumor DNA repair processes. They study how certain mutations can make tumors more vulnerable to treatments that exploit these weaknesses. The lab combines basic science research with clinical trials to develop innovative therapies, including unique antibody treatments and small molecule drug combinations, aimed at improving outcomes for cancer patients.

Dr. Jason Bini's research lab at Yale University focuses on understanding type 1 diabetes, particularly how it affects insulin production in the body. The lab uses advanced imaging techniques like PET and MRI to study changes in the pancreas, including how well insulin-producing cells are functioning. By tracking these changes over time, the lab aims to improve treatment strategies for individuals at risk or newly diagnosed with type 1 diabetes, ultimately enhancing their quality of life.

Dr. Kevan C. Herold's lab at Yale University focuses on understanding and developing treatments for Type 1 diabetes, an autoimmune condition where the immune system attacks insulin-producing cells in the pancreas. The lab uses advanced pancreatic organoid models to investigate how different immune responses affect disease progression and treatment outcomes. They aim to uncover important cellular features that could lead to improved therapies and a better understanding of why some patients respond differently to treatments.